| Class 2 Device Recall Fildes Enrichment |  |
Date Initiated by Firm | February 20, 2012 |
Date Posted | March 23, 2012 |
Recall Status1 |
Terminated 3 on June 18, 2012 |
Recall Number | Z-1282-2012 |
Recall Event ID |
61305 |
Product Classification |
Culture media, general nutrient broth - Product Code JSC
|
Product | Fildes Enrichment, BBL brand, catalog #211866, in 5 ml tubes,10 tubes/package, manufactured by BD Diagnostic Systems, 250 Schilling Circle, Cockeysville, MD 21030.
Fildes Enrichment may be used to enrich a variety of media for the cultivation of various microorganisms. |
Code Information |
Lot 1186346, exp June 22, 2012 Lot 1229762, exp August 03, 2012 |
Recalling Firm/ Manufacturer |
Becton Dickinson & Co. BD Diagnostic Systems 7 Loveton Circle Sparks MD 21152-0999
|
For Additional Information Contact | Kim Cartier 410-316-4418 |
Manufacturer Reason for Recall | In vitro diagnostic reagent is defective and may fail to enhance the growth of microbiological cultures as intended. |
FDA Determined Cause 2 | Nonconforming Material/Component |
Action | Becton Dickinson (BD) sent an "URGENT PRODUCT RECALL" letter dated February 2012 to all affected customers. The letter identifies the product, problem, and actions to be taken by the customers. The letter instructs customers to discontinue use and discard any remaining affected product. BD will issue replacements for the discarded product. Additionally, an Acknowledgment Form was attached for customers to complete and return to the firm via fax to 410-316-4258. Contact BD Technical Services Department for questions regarding this notice. |
Quantity in Commerce | 6930 tubes |
Distribution | Worldwide Distribution-USA (nationwide) and the countries of Belgium, Canada, China, Japan, Mexico, and Taiwan. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|